Research Council Announcements: Grants

Grants announcements from the MassGeneral Hospital for Children Research Council.

Grants

MGH ECOR Formulaic Bridge Funding

What is it? Formulaic Bridge Funding Support is offered to assist MGH Principal Investigators during a lapse or delay in their funding from NIH. To be eligible for Formulaic Bridge Funding, applicants must have applied as a PI for an R01 or R21 grant to support an independent, long-term research program.

The Formulaic Bridge process is open to:

1. Investigators whose grants received a score < or = 20th percentile and have received written communication from the NIH that the grant will not be funded.

2. Investigators whose grants received a fundable score (< or = 20th percentile) but are 3 months past the nominal start date of the the grant.

 

When is the deadline? 7th day of each month.

 

How do I learn more and apply? Click here to read more and apply online.
Visit the ECOR website and specifically the Formulaic Bridge Funding Support under the Awards and Grants tab of the site.

______________________________________________________________________

MGH ECOR Deliberative ISF and Sequestration Relief Funding

ECOR is accepting applications for the August 1st deadline for the Deliberative Interim Support Funding and Sequestration Relief Funding. August is the second of three standing dealines for these awards in 2014, the next one being December 1st.

Deliberative ISF

Open to PIs during a lapse or delay in funding from the NIH or other Federal agency. Investigators must have applied for independent, long-term support (R01, R21, U01, P01). The deliberative ISF process is open to:

1. Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.

2. Investigators whose grants received scores > 20th percentile.

3. Investigators who were awarded Formulaic Bridge Funding and are now requesting additional financial support (in excess of $75,000 for R01s and $37,500 for R21s).

4. A PI who has already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application must apply through the Deliberative Interim Support process for their A1 or A0 resubmission regardless of the score they received on their resubmitted grant.

Sequestration Relief Funding

This is open to Investigators that have experienced a funding shortfall as a result of sequestration and do not qualify for either Formulaic Bridge Funding or Deliberative Interim Support.
 For eligible applicants:


1. The total funded amount, if awarded, will be sourced 50:50 with the Department. For example, if a PI applies for $100,000, then $50,000 will be sourced from ECOR funds and $50,000 will be sourced from Departmental funds.


2. All applications for additional funds must include the Chief’s Letter of Support & Cost Sharing Authorization Form for ECOR Funding.

Deadline: Friday, August 1st, 2014, 5 p.m.

More information:

Deliberative ISF: Click here

Sequestration Relief: Click here

______________________________________________________________________

 

Nominations Open for the 2015 Harrington Prize for Innovation in Medicine

The Harrington Prize for Innovation in Medicine, presented by the American Society for Clinical Investigation (ASCI) and the Harrington Discovery Institute at University Hospitals - part of The Harrington Project for Discovery & Development, honors the physician-scientist who has moved science forward with notable achievements in innovation, creativity and potential for clinical application.

This annual prize provides the awardee with:

  • An unrestricted $20,000 honorarium
  • The Harrington Prize Lecture, delivered at the ASCI/AAP Joint Meeting
  • A review, published in the Journal of Clinical Investigation

 
Nominations are being accepted through August 15, 2014. Click here for more information.

______________________________________________________________________

The Broad Medical Research Program (BMRP) at the Crohn’s and Colitis Foundation of America (CCFA)

In January 2014, the BMRP merged with the CCFA to become the BMRP at CCFA. The goals and philosophy of the program remain intact and nothing has changed except for the management. We remain committed to encouraging clinically relevant novel early stage research. The review process and the commitment to rapid decision making and funding have not changed. We are eagerly accepting new letters of intent consistent with the guidelines of the program. Both the Broad Foundation and the CCFA understand the importance of funding pilot clinically relevant research and are committed to doing so until cures are found.

Apply for a grant here.

______________________________________________________________________

Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org. In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include: 1. Name of the Principal Investigator with appropriate contact information 2. A descriptive title of the potential application 3. Brief description of the project 4. Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities  Please click here for more information and for our internal deadlines.

  • Nutrition Obesity Research Centers (NORCs) (P30) - NEW!
  • Clinical Trials on the Effects of Interventions Aiming to Reduce Chronic Inflammation in Older Adults: Pilot Phase (U01)
  • The National Cancer Institute announces the Outstanding Investigator Award (R35)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

______________________________________________________________________

Private Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@partners.org if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

  • Treatment Trials and Drug Development, National Alliance for the Mentally Ill (NAMI) Stanley Medical Research Institute
  • In-Cycle Grant Opportunities: Research Grant, Alpha-1 Foundation
  • Mentored Research Award (MRA) Program, Hemophilia and Thrombophilia Research Society
  • Charles H. Hood Foundation Child Health Research Awards Program, Health Resources in Action (HRiA) The Medical Foundation
  • Translational Research Grant Program [HeART (Help Accelerate RTT Therapeutics)], Rettsyndrome.org (International Rett Syndrome Foundation)
  • New Investigator Grant, Scleroderma Foundation
  • Established Investigator Grant, Scleroderma Foundation
  • Mentored Training Fellowship Program, Rettsyndrome.org (International Rett Syndrome Foundation)
  • In-Cycle Grant Opportunities: Postdoctoral Research Fellowship Grant, Alpha-1 Foundation
  • Basic Research Grant Program, Rettsyndrome.org (International Rett Syndrome Foundation)

Please click here for further details on these funding opportunities.

_____________________________________________________________________

PCORI Funding Opportunities

For latest newsletter from the Patient-Centered Outcomes Research Institute (PCORI), including funding opportunities, click here.

Late last year, PCORI introduced a new funding initiative that makes substantial investments in larger and longer comparative clinical effectiveness research (CER) projects in the form of “pragmatic studies.” These are studies designed to address important questions faced by typical patients and clinicians, so they include broader and more diverse populations than those found in traditional randomized controlled trials, where narrowly defined groups of participants are studied in highly controlled settings.

The second cycle of this initiative has now been announced. To learn more about this opportunity please click here. Please click here to read the full funding announcement.

______________________________________________________________________

The Boston Biomedical Innovation Center (B-BIC) Launches PILOT and DRIVE Grants

Pre-proposals are now being accepted on a rolling basis. Visit B-BIC.org for more information. B-BIC provides support for the development of devices, diagnostics, and therapeutics related to heart, lung, blood, and sleep disorders. PILOT grants provide up to $50,000 for direct costs for 1 year and DRIVE grants provide up to $200,000 for direct costs for milestones achieved over 1½ to 2 years. It’s recommended that you contact your institutional site miner before submission. B-BIC is a consortium of academia, government, venture capital, non-profit, and industry designed to accelerate translational research.

______________________________________________________________________

NIH Funding Opportunities

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

patient

What will we discover next?

Learn how researchers at MassGeneral Hospital for Children are finding new treatments that advance pediatric care.